Pharmaceuticals and Biotech

  1. 09 Nov 2022  |  Global

    Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis

    Strategic partnering and new product development will enable better biologics for personalized and targeted treatment

    Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...

    $4,950.00

    Special Price $4,455.00 save 10 %

  2. 05 Sep 2022  |  Global

    Technology Growth Opportunities for Exosome-Mediated Drug Delivery

    Exosomes Are Promising Delivery Carriers for Advanced Therapeutics

    Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over synthetic nanoparticles. The widely explored concepts of nanomedicine, nucleic acid therapeutics, and cell-free vacc...

    $4,950.00

    Special Price $4,207.50 save 15 %

  3. 19 Aug 2022  |  North America

    Global Antibody Therapeutics Growth Opportunities

    The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth

    Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...

    $2,450.00

    Special Price $2,082.50 save 15 %

  4. 08 Mar 2022  |  North America

    Global Pharmaceuticals Outlook, 2022

    The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders

    Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...

    $4,950.00

    Special Price $3,712.50 save 25 %

  5. 15 Feb 2022  |  North America

    Global Biologics Contract Development and Manufacturing Organization Profiles and Growth Opportunities

    The Contract Research, Development, and Manufacturing Organization Business Model to Drive Future Growth Potential

    Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

    $2,450.00

    Special Price $1,837.50 save 25 %

  6. 02 Dec 2021  |  North America

    Global Pharmaceutical Industry Growth Opportunities

    2021 Highlights and What to Expect in 2022

    The global pharmaceutical industry is witnessing dynamic trends following the coronavirus pandemic and is adapting to new challenges and opportunities. This study analyzes the 2021 highlights in the global pharmaceutical industry and provides forecasts for the next year and beyond. It addresses the impact of innovative modalities, technologies, ...

    $2,450.00

    Special Price $1,837.50 save 25 %

  7. 30 Nov 2021  |  Global

    Targeted Immunotherapy in Oncology

    Developments in Biotechnology Platforms Leading to Increasing Immuno-oncology Applications

    This research service investigates technologies that propel the development of new targeted immunotherapies, particularly those that deliver therapeutic DNA and proteins. The top 3 growth opportunities focus on enhanced gene delivery systems for greater precision, the support of such systems through novel biotech platforms, and the affordability of...

    $4,950.00

    Special Price $3,712.50 save 25 %

  8. 26 Nov 2021  |  Europe

    EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities

    Future Growth Potential Driven by Capabilities and Expertise in Vaccine Manufacturing

    With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly,...

    $2,450.00

    Special Price $1,837.50 save 25 %

  9. 24 Nov 2021  |  Global

    Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies

    Need for Scalable, Reproducible, and Cost-Effective Manufacturing Processes Driving Growth Opportunities

    The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...

    $4,950.00

    Special Price $3,712.50 save 25 %

  10. 22 Nov 2021  |  Global

    Technological Advances in RNA Stabilization & Delivery

    LNP- and Bioconjugation-based Nonviral RNA Delivery Technologies to Gain Momentum in the Next 3 Years

    RNA therapeutics is a rapidly expanding field of next-generation medicine. RNA therapy typically comprises 4 different classes of molecules: non-codingRNA (ncRNA), antisense oligonucleotide (ASO), messengerRNA (mRNA), and RNA aptamer. Small ncRNAs are like a double-edged sword; they can either up- or down-regulate specific genes. Contrarily, long...

    $4,950.00

    Special Price $3,712.50 save 25 %